Transcatheter aortic valve implantation for the percutaneous treatment of calcific degenerative aortic valve stenosis. Circulatory System
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients undergoing successful transcatheter aortic valve implantation (TAVI), irrespective of device manufacturer, from the inception of the TAVI programme at the participating institution until the 31st December 2013
Exclusion criteria
Exclusion criteria: 1. Previous/pre-existing permanent pacemaker in situ 2. Unsuccessful transcatheter aortic valve implantation procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality at 1 year following transcatheter aortic valve implantation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cardiovascular mortality at 1 year following transcatheter aortic valve implantation 2. Need for permanent pacemaker implantation following transcatheter aortic valve implantation 3. Left ventricular ejection fraction at 30 days and at 1 year following transcatheter aortic valve implantation | — |
Countries
United Kingdom
Contacts
;